Ki67 as a Prognostic and Predictive Biomarker in HR-Positive/HER2-Negative Early Breast Cancer

Course overview

Ki67 as a Prognostic and Predictive Biomarker in HR-Positive/HER2-Negative Early Breast Cancer This 60-minute interactive webinar will feature the expertise of¿a pathologist and an oncologist highlighting important and practice-changing developments related to the use of Ki67 biomarker testing in patients with HR-positive/HER2-negative early breast cancer, such as new clinical data with immediate implications for patient care. Case-based, and with expert perspectives and recommendations, this webinar addresses key educational gaps and controversies related to optimal Ki67 biomarker testing methods, including challenges with standardization, interpreting findings, and potential therapeutic implications for patients with HR-positive/HER2-negative early breast cancer to optimize clinical outcomes. Audience members will be able to download the slides and engage with the experts through live voting and a question-and-answer session that will provide answers in real time. Topics covered will include: Analytical validity of Ki67 as a diagnostic assay, application of results in clinical practice, and relevance to therapy Current and emerging therapies for HR-positive/HER2-negative early-stage breast cancer Current standardized methodologies for Ki67 quantification Optimizing workflows and communications with the multidisciplinary team Only participants in the live videoconference can claim credit here. The session will be recorded and made available at no cost in ASCP's online store and ASCP's YouTube channel, so please check back if you did not attend the live event. The activity offers 1.0 CME/CMLE credit. The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. Credit Designation Statement The ASCP designates this internet live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity. ASCP designates this internet live activity for a maximum of 1.0 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel. For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time Method of Participation To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided on-line. Provided by the American Society for Clinical Pathology in partnership with Clinical Care Options, LLC